Odyssey Investment Partners Acquires ProPharma Group

September 22, 2020

Odyssey Investment Partners has agreed to acquire ProPharma Group from Linden Capital Partners. ProPharma Group, a global provider of regulatory, compliance, pharmacovigilance and medical information services headquartered in Overland Park, Kansas, will be led by CEO Dawn Sherman and the existing management team who are reinvesting alongside Odyssey to pursue organic and inorganic growth.

Buyers
Odyssey Investment Partners, ProPharma Group management team (including Dawn Sherman)
Targets
ProPharma Group
Sellers
Linden Capital Partners
Location
Kansas, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.